Comparison of the effects of Aprepitant and Granisetron in preventing postoperative nausea and vomiting (PONY) in patients undergoing Laparoscopic Cholecystectomy: A double-blind, randomized, controlled study

被引:0
作者
Gokdemir, B. N. [1 ,2 ]
Leblebici, F. [1 ,2 ]
Uslu, A. [1 ,2 ]
Cekmen, N. [1 ,2 ]
Erkent, M. [3 ]
Colak, M. Y. [4 ]
机构
[1] Baskent Univ, Fac Med, Dept Anesthesiol, Ankara, Turkiye
[2] Baskent Univ, Fac Med, Intens Care Unit, Ankara, Turkiye
[3] Baskent Univ, Fac Med, Dept Gen Surg, Ankara, Turkiye
[4] Baskent Univ, Fac Med, Dept Biostat, Ankara, Turkiye
关键词
Aprepitant; granisetron; postoperative nausea and vomiting; laparoscopic cholecystectomy; CONSENSUS GUIDELINES; ONDANSETRON; MANAGEMENT; ANTAGONIST; RISK;
D O I
10.56126/75.3.51
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Postoperative nausea and vomiting (PONV) is one of the most common findings in the first 24 hours after surgery, occurring in 30% of all patients and up to 80% of high-risk patients. We compared aprepitant (a neurokinin-1 receptor antagonist) and granisetron in preventing PONV in patients who underwent laparoscopic Methods: Sixty-one patients (aged 18-90) and the American Society of Anesthesiologists (ASA) I-II class who underwent LC under general anesthesia were enrolled in the study. Our study aimed to compare the incidence of PONV between 0-6, 6-12, and 6-24 hours postoperatively and the need for additional antiemetic requirements primarily and, secondly, detecting VAS scores and additional analgesic requirements for aprepitant and granisetron. Results: Our study observed similar PONV changes in both groups at 0-6 hours. A significantly lower VDS was observed in group A at 30-60 minutes compared to group G (p=0.10). There was no significant difference between groups at other intervals until the 120th minute. Between 6 and 12 hours, Group A had a lower VDS (Verbal Descriptive Scale) than Group G, but there was no statistically significant difference (P>0.05). There was no significant difference between the groups regarding VAS scores, additional analgesic requirements, and adverse effects on patients (p>0.05). Conclusion: We observed that aprepitant may be more effective than granisetron in preventing PONV and can be used safely in patients undergoing LC.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 20 条
[1]  
Apfel Christian C, 2003, Int Anesthesiol Clin, V41, P13, DOI 10.1097/00004311-200341040-00004
[2]   Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial [J].
Bergese, Sergio ;
Viloria, Adolfo ;
Uribe, Alberto ;
Antor, Alejandra ;
Fernandez, Soledad .
TRIALS, 2012, 13
[3]   Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society Recommendations (Part 2) [J].
Caughey, Aaron B. ;
Wood, Stephen L. ;
Macones, George A. ;
Wrench, Ian J. ;
Huang, Jeffrey ;
Norman, Mikael ;
Pettersson, Karin ;
Fawcett, William J. ;
Shalabi, Medhat M. ;
Metcalfe, Amy ;
Gramlich, Leah ;
Nelson, Gregg ;
Wilson, R. Douglas .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 219 (06) :533-544
[4]   Comparison of the Prophylactic Antiemetic Efficacy of Aprepitant Plus Palonosetron Versus Aprepitant Plus Ramosetron in Patients at High Risk for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized-controlled Trial [J].
Choi, Eun Kyung ;
Kim, Dong Gyeong ;
Jeon, Younghoon .
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2016, 26 (05) :354-357
[5]   Aprepitant A Review of its Use in the Prevention of Nausea and Vomiting [J].
Curran, Monique P. ;
Robinson, Dean M. .
DRUGS, 2009, 69 (13) :1853-1878
[6]   Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting:: a randomized, double-blind Phase III trial in patients undergoing open abdominal surgery [J].
Diemunsch, P. ;
Gan, T. J. ;
Philip, E. K. ;
Girao, M. J. ;
Eherharts, L. ;
Irwin, M. G. ;
Pueyo, J. ;
Chelly, J. E. ;
Carides, A. I. ;
Reiss, T. ;
Evans, J. K. ;
Lawson, F. C. .
BRITISH JOURNAL OF ANAESTHESIA, 2007, 99 (02) :202-211
[7]  
Food and Drug Administration (F.D.A.), 2010, Highlights of prescribing information - aprepitant.
[8]   A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting [J].
Gan, Tong J. ;
Apfel, Christian C. ;
Kovac, Anthony ;
Philip, Beverly K. ;
Singla, Neil ;
Minkowitz, Harold ;
Habib, Ashraf S. ;
Knighton, Jennifer ;
Carides, Alexandra D. ;
Zhang, Hong ;
Horgan, Kevin J. ;
Evans, Judith K. ;
Lawson, Francasca C. .
ANESTHESIA AND ANALGESIA, 2007, 104 (05) :1082-1089
[9]   Risk factors for postoperative nausea and vomiting [J].
Gan, Tong J. .
ANESTHESIA AND ANALGESIA, 2006, 102 (06) :1884-1898
[10]   Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting [J].
Gan, Tong J. ;
Belani, Kumar G. ;
Bergese, Sergio ;
Chung, Frances ;
Diemunsch, Pierre ;
Habib, Ashraf S. ;
Jin, Zhaosheng ;
Kovac, Anthony L. ;
Meyer, Tricia A. ;
Urman, Richard D. ;
Apfel, Christian C. ;
Ayad, Sabry ;
Beagley, Linda ;
Candiotti, Keith ;
Englesakis, Marina ;
Hedrick, Traci L. ;
Kranke, Peter ;
Lee, Samuel ;
Lipman, Daniel ;
Minkowitz, Harold S. ;
Morton, John ;
Philip, Beverly K. .
ANESTHESIA AND ANALGESIA, 2020, 131 (02) :411-448